Xeroderma pigmentosum variant associated with multiple cancers

Photodermatology Photoimmunology and Photomedicine

Volumn 15, Issue 3-4, 1999, Pages 127-132

  Kuwamoto, Kazue ^a   Miyauchi Hashimoto, H ^a   Isei, T ^a   Horio, T ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Internal malignancy; Multiple skin cancers; Xeroderma pigmentosum

Indexed keywords

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; CASE REPORT; HUMAN; JAPAN; MALE; PRIORITY JOURNAL; RADIATION DOSE; SKIN CANCER; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET B RADIATION; XERODERMA PIGMENTOSUM;

EID: 0033027854     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.1999.tb00072.x     Document Type: Article

References (27)

1. Cleaver JE. Defective repair replication of DNA in xeroderma pigmentosum. Nature 1968: 218: 652-656.
2. Robbins JH, Kraemer KH, Lutzner MA, Festoff BW, Coon HG. Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med 1974: 80: 221-248.
3. Cleaver JE, Bootsma D. Xeroderma pigmentosum: biochemical and genetic characteristics. Annu Rev Genet 1975: 9: 18-38.
4. Epstein JH, Fukuyama K, Reed WB, Epstein WL. Defect in DNA synthesis in skin of patients with xeroderma pigmentosum demonstrated in vivo. Science 1970: 168: 1477-1478.
5. Kraemer HK, Lee MM, Scotto J. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis 1984: 5: 511-514.
6. Satoh K, Watatani M, Ikenaga M et al. Sensitivity to UV radiation of fibroblasts from a Japanese group A xeroderma pigmentosum patient with mild neurological abnormalities. Br J Dermatol 1987: 16: 101-108.
7. Takebe H, Miki Y, Kozuka T et al. DNA repair characteristics and skin cancers of xeroderma pigmentosum patients in Japan. Cancer Res 1977: 37: 490-495.
8. Wang Y, Kobayashi K, Chang HR et al. Assignment of a Chinese xeroderma pigmentosum patient from Taiwan to complementation group C. J Radiat Res 1991: 32: 181-190.
9. Kraemer KH, Coon HG, Petinga RA, Barrett SF, Rahe AE, Robbins JH. Genetic heterogeneity in xeroderma pigmentosum: complementation groups and their relationship to DNA repair rates. Proc Nat Acad Sci USA 1975: 72: 59-63.
10. Fujiwara Y, Uehara Y, Ichihashi M, Yamamoto Y, Nishioka K. Assignment of 2 patients with xeroderma pigmentosum to complementation group E. Mutat Res 1985: 145: 55-61.
11. Nishigori C, Ishizaki K, Takebe H, Imamura S, Hayakawa M. A case of xeroderma pigmentosum group F with late onset of clinical symptoms. Arch Dermatol 1986: 122: 510-511.
12. Keijzer W, Jaspers NG, Abrahams PJ et al. A seventh complementation group in excision-deficient xeroderma pigmentosum. Mutat Res 1979: 62: 183-190.
13. Noda A, Ikenaga M. Genetic complementaion groups of Cockayne syndrome in Japan (abstract). J Radiat Res 1985: 26: 52.
14. Itoh T, Ono T, Yamaizumi M. A new UV-sensitive syndrome not belonging to any complementation groups of xeroderma pigmentosum or Cockayne syndrome: siblings showing biochemical characteristics of Cockayne syndrome without typical clinical manifestations. Mutat Res 1994: 314: 233-248.
15. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 1987: 123: 241-250.
16. Kraemer KH, Lee MM, Andrews AD, Lambert WC. The role of sunlight and DNA repair in melanoma and non-melanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 1994: 130: 1018-1021.
17. Lehmann AR, Kirk-Bell S, Arlett CF et al. Xeroderma pigmentosum cells with normal levels of excision repair have a defect in DNA synthesis after UV-irradiation. Proc Nat Acad Sci USA 1975: 72: 219-223.
18. Arlett CF, Harcourt SA, Broughton BC. The influence of caffeine on cell survival in excision-proficient and excision-deficient xeroderma pigmentosum and normal human cell strains following ultraviolet-light irradiation. Mutat Res 1975: 33: 341-346.
19. Maher VM, Ouellette LM, Mittlestat M, McCormick JJ. Synergistic effect of caffeine on the cytotoxicity of ultraviolet irradiation and of hydrocarbon epoxides in strains of xeroderma pigmentosum. Nature 1975: 258: 760-763.
20. Ichihashi M, Fujiwara Y. Clinical and photobiological characteristics of Japanese xeroderma pigmentosum variant. Br J Dermatol 1981: 105: 1-12.
21. Dupuy JM, Lafforet D. A defect of cellular immunity in xeroderma pigmentosum. Clin Immunol Immunopathol 1974: 3: 52-58.
22. Morison WL, Bucana C, Hashem N, Kripke ML, Cleaver JE, German JL. Impaired immune function in patients with xeroderma pigmentosum. Cancer Res 1985: 45: 3929-3931.
23. Norris PG, Limb GA, Hamblin AS et al. Immune function, mutant frequency, and cancer risk in the DNA repair defective genodermatoses xeroderma pigmentosum, Cockayne's syndrome, and trichothiodystrophy. J Invest Dermatol 1990: 94: 94-100.
24. Gaspari AA, Fleisher TA, Kraemer KH. Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum. J Clin Invest 1993: 92: 1135-1142.
25. Miyauchi-Hashimoto H, Tanaka K, Horio T. Enhanced inflammation and immunosuppression by ultraviolet radiation in xeroderma pigmentosum group A (XPA) model mice. J Invest Dermatol 1996: 107: 343-348.
26. Miyauchi-Hashimoto H, Okamoto H, Tanaka K, Horio T. Ultraviolet (UV) radiation-induced suppression of natural killer (NK) cell activity was enhanced in xeroderma pigmentosum group A (XPA) model mice (abstract). J Invest Dermatol 1998: 110: 696.
27. Mamada A, Miura K, Tsunoda K, Hirose I, Furuya M, Kondo S. Xeroderma pigmentosum variant associated with multiple skin cancers and lung cancer. Dermatology 1992: 184: 177-181.